Abstract:Objective To investigate the clinical risk factors related to the cirrhosis development in patients with hepatitis B virus infection. Methods A total of 988 participants with hepatitis B virus infection were collected for this study in Zhong Shan Hospital affiliated with Fu Dan University between January 2009 and January 2011. All of them were Chinese Han nationality from Shanghai and its surrounding area. Their information, including hepatitis history, serum test, liver imaging, and liver histology if available, were collected. They were divided into healthy recovered and chronic hepatitis group, the later was subdivided into cirrhotic group and non-cirrhotic group. The general informations and clinical determination datas were compared with statistical analysis by using SPSS 18.0 and STATA 11.0 software. Results (1) The ratio of male/female participants was 736/252, and the average age was 50.8±13.2. The numbers of participants in healthy recovered group, non-cirrhotic chronic hepatitis and cirrhotic group were 274, 285, and 429, respectively, and the average ages were 56.7±13.6, 49.2±11.5, and 47.5±13.5, respectively. Chronic hopatitis B (CHB) familial history was found in 2.2% participants of the healthy recovered group and 47.5% participants of chronic hepatitis group. The vertical infection rates were 56.3% in healthy recovered group, and 93.7% in chronic hepatitis group, which have significant difference between them. For chronic hepatitis group, the vertical rates of non-cirrhotic and cirrhotic group were 89.4% and 96.4%, respectively, which also have significant difference between them. The vertical infection was a risk factor for chronicity of hepatitis B (OR=15.02, 95% CI:9.57-23.94) and the development of cirrhosis (OR=3.15, 95%CI:1.39-7.45). The duration of disease of cirrhotic patients (44.1±9.5 years) was longer than that of non-cirrhotic CHB patients (39.3±9.8 years). The ratio of male patients in cirrhotic group was also significantly higher than that in non-cirrhotic group (70.2%) and the duration of disease for male patients (41.7±9.3 years) were shorter than that of female patients (45.0±11.4 years).(2) The levels of liver function rests were significantly different among healthy recover, non-cirrhotic, and cirrhotic group of CHB patients. There were negative correlation between HBsAg and HBV DNA in HBeAg positive patients (r=-0.43);However positive correlation in HBeAg negative patients (r=0.23) was observed. HBsAg level, which was higher than 1 000 COI, of cirrhotic patients (89.5%) was significant higher than that of non-cirrhotic patients (89.5%) (OR=1.86, 95% CI:1.18-2.94). No correlation was found betweem HBV DNA level and the duration of disease of CHB (P=0.21). Although HBV DNA level in cirrhotic group was significantly higher than that in non-cirrhotic group (2.875±2.68 log10copies/mL), the ratio of patients with HBV DNA level, which was higher than 5 log10copies/mL in cirrhotic group (31%) was significantly lower than that in non-cirrhotic group(57.2%). Conclusion The factors associated with cirrhosis development in CHB patients include duration of diseases, familial history, route of infection (vertical infection), male gender, the level of HBsAg(higher than 1 000 COI), and HBV DNA level.

Evaluation of the relationship between central serous chorioretinopathy and liver cirrhosis: A nationwide, population-based study

Central Serous Chorioretinopathy Secondary to Drugs: a Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).

Relationship between heart failure and central serous chorioretinopathy: A cohort study in Taiwan

Increased Risk of Glaucoma Development in Patients with Central Serous Chorioretinopathy: Results of a 11-Year Population-Based Cohort Study

Hepatitis C Virus Infection is Positively Associated with Gallstones in Liver Cirrhosis.

Risk Factors and VEGF, hs‐CRP, and ESR in Central Serous Chorioretinopathy

Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies

Genetic Associations of Central Serous Chorioretinopathy: a Systematic Review and Meta-Analysis

Evaluation of the clinical risk factors associated with liver cirrhosis in patients with chronic hepatitis B viral infection

Long-term Risks for Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes

[An Analysis of Clinical Characteristics and Risk Factors of Cirrhosis-Related Hepatocellular Carcinomas in Patients with Hepatitis C Virus Infection].

Risk Factors for Persistent or Recurrent Central Serous Chorioretinopathy

Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study

In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy

629 CEREBRAL OEDEMA IS RARE IN ACUTE-ON-CHRONIC LIVER FAILURE (AOCLF)

Comparison of Risk Factors for Cholangiocarcinoma and Hepatocellular Carcinoma: A Prospective Cohort Study in Korean Adults

Analysis of Cytokine Levels Based on Optical Coherence Tomography Findings in Acute and Chronic Central Serous Chorioretinopathy

Temporal Association between Topical Ophthalmic Corticosteroid and the Risk of Central Serous Chorioretinopathy

Biometric risk factors for central serous chorioretinopathy

Therapies for Central Serous Chorioretinopathy: A Report by the American Academy of Ophthalmology

Evaluation of carotid intima-media thickness measurements in patients with central serous chorioretinopathy